|
|
Article: U.S. Patent Disclosures.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Celgene Corp., of Warren, N.J., was granted U.S. Patent No. 6,541,605 covering polypeptides of mitogen-activated protein kinase kinases that are involved in the p38 and c-Jun N-terminal kinase pathways.
Chiral Quest Inc., of State College, Pa., said the Penn State Research Foundation received U.S. Patent No. 6,534,657 covering the compositions of matter and use for a series of chiral phosphine ligands and catalysts with forrocene backbones. Chiral Quest exclusively licenses the patent from its chief technology officer.
Diversa Corp., of San Diego, was granted U.S. Patent No. 6,537,776 directed to Tunable GeneReassembly, its next-generation evolution ...